IP Position

Drawbridge has a robust intellectual property position on Phaxan™. A PCT was filed in January 2011 with national phase filings proceeding worldwide in key jurisdictions. Patents arising from PCT/AU2011/00050, entitled “Anaesthetic Formulation” have been granted in Australia, Canada, China, Europe (37 countries), Hong Kong, Japan, New Zealand, Russia, Singapore, South Korea, South Africa, United Kingdom and the United States of America.